癌症护理中细胞、分子和基因组技术的卫生服务研究议程。

A health services research agenda for cellular, molecular and genomic technologies in cancer care.

作者信息

Wideroff Louise, Phillips Kathryn A, Randhawa Gurvaneet, Ambs Anita, Armstrong Katrina, Bennett Charles L, Brown Martin L, Donaldson Molla S, Follen Michele, Goldie Sue J, Hiatt Robert A, Khoury Muin J, Lewis Graham, McLeod Howard L, Piper Margaret, Powell Isaac, Schrag Deborah, Schulman Kevin A, Scott Joan

机构信息

National Cancer Institute, Bethesda, MD, USA.

出版信息

Public Health Genomics. 2009;12(4):233-44. doi: 10.1159/000203779. Epub 2009 Feb 20.

DOI:10.1159/000203779

PMID:19367091

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2844634/

Abstract

BACKGROUND

In recent decades, extensive resources have been invested to develop cellular, molecular and genomic technologies with clinical applications that span the continuum of cancer care.

METHODS

In December 2006, the National Cancer Institute sponsored the first workshop to uniquely examine the state of health services research on cancer-related cellular, molecular and genomic technologies and identify challenges and priorities for expanding the evidence base on their effectiveness in routine care.

RESULTS

This article summarizes the workshop outcomes, which included development of a comprehensive research agenda that incorporates health and safety endpoints, utilization patterns, patient and provider preferences, quality of care and access, disparities, economics and decision modeling, trends in cancer outcomes, and health-related quality of life among target populations.

CONCLUSIONS

Ultimately, the successful adoption of useful technologies will depend on understanding and influencing the patient, provider, health care system and societal factors that contribute to their uptake and effectiveness in 'real-world' settings.

摘要